Abstract

Assisted suicide is the act of ending one's own life with the aid of a clinician who supplies, but does not administer, the lethal means. It sits at the intersection of psychiatry, bioethics, and law, and poses a distinctly cognitive-psychological question: what mental states and capacities underlie a terminally ill person's considered wish to die? Research distinguishes a fluctuating desire for death driven by treatable depression and hopelessness from a stable, reasoned request grounded in concerns about autonomy and dignity. Evaluating such a request requires a formal judgment of decision-making capacity, whose stringency rises with the gravity of the choice. This article surveys the empirical psychology of the desire for hastened death, the assessment of capacity at the end of life, and the patterns observed where the practice is legally regulated.

Keywords: desire for death, decision-making capacity, hopelessness, end-of-life care, autonomy

Assisted suicide denotes a death in which a competent person voluntarily ingests a lethal medication that a physician has prescribed at the patient's explicit request, the physician providing the means but not performing the final act. It is distinguished from euthanasia, in which a clinician administers the agent directly, and from the withdrawal of life-sustaining treatment, which permits an underlying disease to run its course. The construct is indexed in the behavioral and terminal-care branches of the scientific literature, yet its substance is psychological: a request to hasten death is a decision, taken by a person whose judgment, mood, and sense of the future are all under extraordinary strain. The empirical study of that decision began in earnest when Chochinov and colleagues (1995) measured the desire for death directly in terminally ill patients and found it bound tightly to depression rather than to physical decline alone.

Key Takeaways

  • Assisted suicide involves a physician supplying lethal means that the patient self-administers, which separates it from euthanasia and from withdrawing treatment.
  • A sustained desire for hastened death is strongly predicted by depression and hopelessness, and far less by pain, so an expressed wish to die is a signal to assess mood, not a settled verdict.
  • The will to live fluctuates markedly from day to day in the terminally ill, which makes a single statement of intent an unreliable basis for an irreversible act.
  • Evaluating a request turns on decision-making capacity, assessed through understanding, appreciation, reasoning, and the expression of a choice, against a threshold that rises with the stakes.
  • Where the practice is regulated, patients cite loss of autonomy, loss of dignity, and the inability to engage in meaningful activity far more often than uncontrolled pain.

What Assisted Suicide Is

Assisted suicide is defined by three features acting together: the death is intended, the lethal means are provided by a clinician at the patient's request, and the final act is carried out by the patient. Removing any one of them changes the category. When the clinician administers the agent, the act is euthanasia; when no lethal agent is involved and treatment is simply stopped or not started, the death is one of allowing to die; when the intention is to relieve symptoms and death is a foreseen but unintended side effect of adequate sedation, it falls under the doctrine of double effect. These distinctions are not merely legal bookkeeping. They mark different psychological situations for the patient and different responsibilities for the clinician, and the public debate frequently conflates them.

The terminology is itself contested. Advocates of legalization favor the phrases physician-assisted death or medical aid in dying, reserving suicide for self-killing that is not medically supervised and not a response to terminal illness; opponents hold that the act is suicide by definition and that softer language obscures what is happening. The scientific indexing vocabulary retains the heading assisted suicide as the neutral descriptor, and this article uses it in that descriptive sense, without endorsing either side of the normative argument. What the cognitive-psychological literature can contribute is not a verdict on whether the act should be permitted, but evidence about the states of mind from which the request arises and the reliability of the judgments involved.

The Desire for Hastened Death

The central empirical finding of this field is that a wish to die is not a transparent readout of suffering. Chochinov and colleagues (1995) interviewed terminally ill patients in palliative care and found that a genuine, sustained desire for death occurred in a minority, and that where it occurred it was associated far more strongly with clinical depression than with the severity of pain or the nearness of death. Breitbart and colleagues (2000) sharpened the result: in patients with terminal cancer, the desire for hastened death was predicted by depression and, most powerfully, by hopelessness, a cognitive orientation toward the future that is partly separable from depressed mood. Hopelessness contributed to the wish to die over and above depression itself, which is why an assessment that screens only for low mood can miss the state most predictive of a request. This separability has since been formalized as demoralization syndrome, a state of hopelessness, loss of meaning, and existential distress that can arise with or without major depression and that a systematic review identifies as a distinct target for assessment and treatment in advanced disease (Robinson et al., 2015). The distinction is clinically consequential, because a demoralized patient may deny depressed mood yet hold exactly the hopeless outlook that most strongly predicts a wish to die.

The demonstration below makes the relationship concrete. It models a latent desire-for-hastened-death score as a logistic function of depression and hopelessness, with physical pain deliberately given no weight, so that the reader can see the counterintuitive pattern the data support: holding mood and outlook fixed, moving pain from low to high does nothing to the predicted wish, whereas moving hopelessness alone moves it sharply.

A second finding compounds the first. The will to live, the positive counterpart of the desire for death, is not stable. Chochinov and colleagues (1995) and subsequent palliative-care research documented that it fluctuates substantially over hours and days, tracking swings in depression, anxiety, and the sense of being a burden. A patient may state a firm wish to die in the morning and retract it by evening. For a decision that cannot be revisited, this instability is the single most important psychological fact, because it means that any one expression of intent is a sample from a moving distribution rather than a fixed preference.

Assessing Decision-Making Capacity

Because a request to hasten death is a decision, the law and clinical ethics ask whether the person making it has the capacity to do so. Appelbaum (2007) codified the standard that is now near-universal in clinical practice: capacity is assessed through four abilities. The patient must be able to understand the relevant information, to appreciate how it applies to their own situation, to reason with it by weighing options against their own values, and to express a choice. Capacity in this account is not global but decision-specific; a person may have the capacity to refuse a blood draw yet lack it for a complex, irreversible choice.

Crucially, the threshold is not fixed. Appelbaum's framework incorporates a sliding scale: the more serious and irreversible the consequences of the decision, the higher the standard of capacity required before the choice is honored. A request to end one's life sits at the extreme of that scale, so the evidence of intact understanding, appreciation, and reasoning demanded of it is correspondingly stringent. The interactive model below implements this logic. It composites the four abilities into an overall capacity score and compares it against a threshold that the reader can raise from a low-stakes everyday decision to the gravity of a life-ending one, showing how the same patient can clear the bar for a minor choice and fall short of it for the gravest.

The relationship between capacity and mood is where the two threads meet. Depression can impair capacity without abolishing it, chiefly by distorting appreciation and reasoning: a severely depressed patient may understand a prognosis perfectly yet apply to it a conviction of worthlessness or a certainty of unrelievable suffering that the facts do not warrant. Kim and colleagues (2016), reviewing the records of patients with psychiatric disorders who received euthanasia or assisted suicide in the Netherlands, found that judgments of capacity and of whether suffering was irremediable were often difficult, contested among clinicians, and made under conditions of real uncertainty. The finding does not settle the ethical debate, but it shows that capacity assessment at the end of life is not a formality.

The Stated Reasons and the Regulated Experience

Where assisted dying is legal, systematic reporting has accumulated a clear picture of who requests it and why. Even before legalization shaped the data, Wilson and colleagues (2000) surveyed terminally ill patients directly and found that a minority would seriously consider a hastened death, with that interest again tied to depression and to a wish for control rather than to pain alone. Sullivan and colleagues (2000), reporting the second year of Oregon's Death with Dignity Act, and later Blanke and colleagues (2017), characterizing eighteen years of the same statute, found that patients who pursue assisted death are disproportionately well-educated, insured, and enrolled in hospice, and that the concerns they cite are overwhelmingly existential rather than physical. Loss of autonomy, the loss of the ability to engage in activities that make life enjoyable, and loss of dignity dominate the stated reasons; inadequate pain control, or fear of it, ranks far lower. Ganzini and colleagues (2008) added a critical safeguard finding: among Oregonians who requested aid in dying, a measurable minority met criteria for depression or anxiety, and some of those patients received and used lethal prescriptions, indicating that the required psychiatric gatekeeping does not catch every case of treatable disorder. Smith and colleagues (2011) later examined the quality of the dying experience itself among Oregonians who used the law and found it broadly comparable to that of other hospice deaths, a descriptive result that bears on the practice's effects without settling its ethics.

The demonstration below contrasts the lay assumption about why people seek assisted death with the pattern the reporting consistently shows, letting the reader toggle between the two and see how far physical pain sits from the top of the patients' own list of concerns.

A recurring and psychologically revealing pattern is that a substantial share of patients who obtain a lethal prescription never ingest it. Blanke and colleagues (2017) and Al Rabadi and colleagues (2019), tracking trends across Oregon and Washington, documented both a steady rise in participation over time and this persistent gap between prescriptions written and prescriptions used. The possession of the means appears to function partly as a restoration of control: for some patients the reassurance that an exit exists is itself therapeutic, and the option is held in reserve rather than exercised.

Figure 1

Two Routes from Terminal Illness to a Request to Hasten Death

A schematic of two pathways leading to a request to hasten death Terminal illness branches into two pathways. An upper, treatable route runs through depression and hopelessness to a fluctuating desire for death, marked reversible. A lower route runs through concerns about autonomy and dignity to a stable, reasoned request. A capacity assessment sits before the outcome. Terminal illness Depression and hopelessness Autonomy and dignity concerns Fluctuating desire for death (reversible) Stable, reasoned request Capacity assessment
Note. The upper route is driven by treatable mood disorder and yields a wish that is often reversible; the lower route reflects values-based concerns. A capacity assessment stands before any outcome, and the two routes are not mutually exclusive in a given patient. Original schematic.
ConceptWho provides the lethal agentWho performs the final actIntention
Assisted suicidePhysician prescribesPatient self-administersDeath intended
EuthanasiaPhysicianPhysician administersDeath intended
Withdrawal of treatmentNo lethal agentDisease runs its courseDeath allowed, not caused
Palliative sedationPhysician (sedative)Physician administers for symptom reliefRelief intended, death foreseen

Worked Example

Consider the logistic model of the desire for hastened death used in the first demonstration, with the latent score computed as desire = 100 / (1 + e^(−z)), where z = −6 + 0.045·D + 0.06·H, and D is a depression index and H a hopelessness index, each on a 0-to-100 scale. Physical pain does not enter the equation, reflecting the finding that it does not independently predict the sustained wish to die.

Take a patient with a depression index of 60 and a hopelessness index of 70. Then z = −6 + (0.045 × 60) + (0.06 × 70) = −6 + 2.7 + 4.2 = 0.9, and the predicted desire score is 100 / (1 + e^(−0.9)) = 100 / 1.4066 = 71.1. The wish to die is strong. Now suppose this patient's pain is severe but their mood and outlook are treated successfully, bringing both indices down to 20. Then z = −6 + (0.045 × 20) + (0.06 × 20) = −6 + 0.9 + 1.2 = −3.9, and the predicted score is 100 / (1 + e^(3.9)) = 100 / 50.40 = 2.0. The desire has all but vanished, even though the physical suffering is unchanged. The arithmetic recapitulates the empirical claim of Breitbart and colleagues (2000): the lever that moves the wish to die is the treatable cognitive-affective state, not the pain.

Discussion

The convergent message of four decades of research is that a request to hasten death is a psychological event with a mixed etiology, and that the clinically decisive question is which etiology is operating. One route runs through depression and hopelessness and yields a wish that is frequently reversible once the mood disorder is treated; the other runs through stable, values-based concerns about autonomy and dignity and yields a request that treatment of mood will not dissolve. The two routes can coexist in the same patient, and disentangling them is the substance of a serious assessment. That the existential route dominates the stated reasons is not an artifact of a single jurisdiction: Hendry and colleagues (2013), systematically reviewing the international literature on the views of patients, carers, and the public, found that the wish for autonomy and control over the manner of dying recurs across settings as the central motive people give for wanting the right to die. Maytal and Stern (2006) argued in a clinical case discussion that the appropriate first response to an expressed wish to die is not to adjudicate it but to investigate it, treating the statement as the opening of a conversation about suffering, meaning, and unmet need rather than as a settled request to be granted or refused.

This reframing has a therapeutic corollary. If hopelessness and a collapse of meaning drive much of the desire for death, then interventions that restore meaning should reduce it, and the evidence supports this. Chochinov and colleagues (2005) developed dignity therapy, a brief psychotherapy that elicits and records what patients wish to be remembered for, and showed that it reduced suffering and bolstered the sense of meaning near the end of life. Breitbart's meaning-centered psychotherapy, grounded in the same logic, targets the existential concerns that the Oregon data place at the top of patients' stated reasons. The existence of effective treatments for the drivers of the wish to die is precisely what makes the capacity assessment ethically weighty: a request shaped by a treatable condition is not yet the autonomous choice it may appear to be.

Cognitive Implications

Assisted suicide is indexed as a behavior and a terminal-care practice, not as a cognitive construct, yet its central problems are cognitive through and through. A request to hasten death is a judgment under uncertainty, made about an irreversible outcome, by a person whose information-processing is shaped by mood, fatigue, medication, and a foreshortened sense of the future. The appreciation and reasoning components of Appelbaum's (2007) capacity standard are explicitly cognitive: appreciation is the ability to apply general information to one's own case without the distortion of a mood-congruent belief, and reasoning is the manipulation of that information against one's own values. Depression degrades both not by removing knowledge but by biasing its use, in the same way that affective state biases probability estimates and prospective judgments in the wider decision-making literature.

The instability of the will to live connects the topic to the psychology of preference construction. A preference that swings with the time of day is not a stable attitude being reported but an attitude being constructed in the moment, under the influence of transient states. This is why the regulatory architecture of every jurisdiction that permits assisted death imposes waiting periods and repeated requests: the safeguards are, in effect, an attempt to sample the preference distribution more than once and to privilege its stable component over its volatile one. Seen this way, the clinical and legal apparatus around assisted dying is applied decision psychology, built to protect a genuine choice from the momentary states that can counterfeit it.

Current Directions

The research frontier has moved from whether a desire for death can be measured to how capacity and irremediability can be judged in the hardest cases. The extension of assisted dying to patients whose primary diagnosis is psychiatric rather than terminal has made this urgent. Kim and colleagues (2016) analyzed Dutch review-committee records for patients with psychiatric disorders and documented how often capacity and the irremediability of suffering were genuinely contested, with physicians disagreeing and formal psychiatric input sometimes absent. The finding has reframed the debate around a cognitive problem rather than a purely moral one: can a condition that itself distorts judgment supply the settled judgment that a request to die is supposed to express?

A second current is comparative and epidemiological. Emanuel and colleagues (2016) synthesized attitudes and practices across the United States, Canada, and Europe, documenting that assisted dying remains statistically rare, is pursued mainly by patients with cancer, and is driven by the loss of autonomy more than by pain, across very different legal regimes. Al Rabadi and colleagues (2019) tracked the steady rise in participation in the two longest-running United States programs. The convergence of these patterns across jurisdictions suggests that the psychology of the request is more stable than the law governing it, and that the existential profile first documented in Oregon generalizes.

Common Misconceptions

People request assisted death mainly to escape uncontrolled physical pain.
Across years of reporting, patients cite loss of autonomy, loss of dignity, and the inability to engage in meaningful activity far more often than pain, which ranks near the bottom of their stated concerns (Blanke et al., 2017). The pain assumption persists because it is the most intuitive reason an onlooker imagines, not the one patients give.
Anyone who is terminally ill and asks to die is clinically depressed.
A sustained desire for death is a minority experience even in palliative care, and when it occurs it is associated with depression and hopelessness rather than being universal (Chochinov et al., 1995). Depression is a strong predictor of the wish, not a synonym for terminal illness, which is why screening rather than assumption is required.
A clear statement of the wish to die settles the matter.
The will to live fluctuates substantially over short intervals in the terminally ill, so a single statement samples a moving state rather than a fixed preference (Chochinov et al., 1995). This instability is the reason jurisdictions require waiting periods and repeated requests rather than acting on one declaration.

Glossary

Advance directive.
A legal document in which a person records treatment preferences or names a surrogate to take effect if they later lose decision-making capacity.
Autonomy.
The capacity and right of a person to govern their own choices; the most frequently cited reason patients give for seeking assisted death.
Death with Dignity Act.
The Oregon statute, enacted in 1997, that first legalized physician-assisted death in the United States and established the reporting framework much research relies on.
Decision-making capacity.
The clinical ability to understand, appreciate, and reason about a specific choice and to express it; assessed decision by decision, not globally.
Demoralization syndrome.
A state of hopelessness, loss of meaning, and existential distress in serious illness, distinguished from major depression and recognized as a distinct driver of the wish to die.
Desire for hastened death.
A measurable wish for death to come sooner, distinguished in research from passive acceptance of dying and predicted chiefly by depression and hopelessness.
Dignity therapy.
A brief psychotherapy that elicits and records what a dying patient wishes to be remembered for, developed to relieve end-of-life distress and restore meaning.
Double effect.
The doctrine that an action taken to relieve suffering is permissible even if it foreseeably hastens death, provided death is not the intended aim.
Euthanasia.
The intentional ending of a patient's life by a clinician who administers the lethal agent directly, distinguishing it from assisted suicide.
Hopelessness.
A negative orientation toward the future, partly separable from depressed mood, that is among the strongest predictors of the desire for hastened death.
Palliative care.
Specialized medical care focused on relieving the symptoms and stress of serious illness, aiming to improve quality of life rather than to cure.
Palliative sedation.
The use of sedatives to relieve otherwise intractable symptoms at the end of life, sometimes to the point of unconsciousness, with relief rather than death as the aim.
Physician-assisted death.
A term favored by proponents for assisted suicide performed under medical regulation for a terminally ill patient, emphasizing the clinical context.
Terminal illness.
A disease that is expected to cause death within a limited time, commonly defined in statute as a prognosis of six months or less.
Will to live.
The positive counterpart of the desire for death; a subjective wish to go on living that fluctuates markedly over short intervals in the terminally ill.

Key Researchers

William Breitbart

(b. 1951). Chair of the Department of Psychiatry and Behavioral Sciences at Memorial Sloan Kettering Cancer Center; established the link between depression, hopelessness, and the desire for hastened death and developed meaning-centered psychotherapy for advanced cancer. ORCID - Wikipedia - Faculty Page

Harvey Max Chochinov

(b. 1958). Distinguished Professor of Psychiatry at the University of Manitoba; measured the desire for death directly in terminally ill patients and developed dignity therapy to relieve end-of-life suffering. ORCID - Wikipedia - Faculty Page

Ezekiel J. Emanuel

(b. 1957). Vice Provost for Global Initiatives and Professor of Medical Ethics and Health Policy at the University of Pennsylvania; led the international comparative study of attitudes and practices of euthanasia and assisted suicide. ORCID - Wikipedia - Faculty Page

Linda Ganzini

. Professor Emerita of Psychiatry at Oregon Health and Science University; led the empirical study of the psychiatric dimensions of the Oregon Death with Dignity Act, including the prevalence of depression and anxiety among those requesting aid in dying. Google Scholar

Scott Y. H. Kim

. Senior Investigator in the Department of Bioethics at the National Institutes of Health; studies decision-making capacity and the ethics of euthanasia and assisted suicide for patients with psychiatric disorders. Faculty Page - Google Scholar

Frequently Asked Questions

What is the difference between assisted suicide and euthanasia?

In assisted suicide the physician supplies a lethal medication that the patient takes themselves, whereas in euthanasia the clinician administers the agent directly. The distinction turns on who performs the final act, and it carries different legal and psychological weight in every jurisdiction (Emanuel et al., 2016).

Do most people who seek assisted death do so because of pain?

No. Reporting from jurisdictions where the practice is legal shows that loss of autonomy, loss of dignity, and the inability to engage in meaningful activity are cited far more often than pain, which ranks low among patients' stated reasons (Blanke et al., 2017).

Is a wish to die the same as being suicidal?

Research distinguishes a sustained desire for hastened death in terminal illness from the suicidality of psychiatric crisis, though the two overlap. A sustained wish occurs in a minority of palliative patients and is strongly associated with depression and hopelessness (Chochinov et al., 1995).

How do clinicians decide whether a person has the capacity to request death?

Capacity is assessed through four abilities: understanding the information, appreciating how it applies to oneself, reasoning with it, and expressing a choice, against a threshold that rises with the gravity of the decision (Appelbaum, 2007).

Can depression affect a person's capacity to make this decision?

Yes. Depression can impair appreciation and reasoning without abolishing understanding, biasing how a person applies accurate information to their own case, which is why capacity assessment at the end of life is demanding rather than routine (Kim et al., 2016).

Does treating depression change the wish to die?

Often it does. Because the desire for hastened death is driven largely by depression and hopelessness rather than by pain, treating the mood disorder frequently reduces or removes the wish (Breitbart et al., 2000).

Do all patients who get a lethal prescription use it?

No. A substantial share of patients who obtain the means never ingest them, and the possession itself appears to restore a sense of control that some find sufficient (Al Rabadi et al., 2019).

Are there psychological treatments aimed at the reasons people seek death?

Yes. Dignity therapy and related meaning-centered interventions target the loss of meaning and dignity that drive many requests, and have been shown to relieve end-of-life distress (Chochinov et al., 2005).

References

Al Rabadi, L., LeBlanc, M., Bucy, T., Ellis, L. M., Hershman, D. L., Meyskens, F. L., Taylor, L., & Blanke, C. D. (2019). Trends in medical aid in dying in Oregon and Washington. JAMA Network Open, 2(8), e198648. https://doi.org/10.1001/jamanetworkopen.2019.8648

Appelbaum, P. S. (2007). Assessment of patients' competence to consent to treatment. New England Journal of Medicine, 357(18), 1834-1840. https://doi.org/10.1056/NEJMcp074045

Blanke, C., LeBlanc, M., Hershman, D., Ellis, L., & Meyskens, F. (2017). Characterizing 18 years of the Death With Dignity Act in Oregon. JAMA Oncology, 3(10), 1403-1406. https://doi.org/10.1001/jamaoncol.2017.0243

Breitbart, W., Rosenfeld, B., Pessin, H., Kaim, M., Funesti-Esch, J., Galietta, M., Nelson, C. J., & Brescia, R. (2000). Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer. JAMA, 284(22), 2907-2911. https://doi.org/10.1001/jama.284.22.2907

Chochinov, H. M., Wilson, K. G., Enns, M., Mowchun, N., Lander, S., Levitt, M., & Clinch, J. J. (1995). Desire for death in the terminally ill. American Journal of Psychiatry, 152(8), 1185-1191. https://doi.org/10.1176/ajp.152.8.1185

Chochinov, H. M., Hack, T., Hassard, T., Kristjanson, L. J., McClement, S., & Harlos, M. (2005). Dignity therapy: A novel psychotherapeutic intervention for patients near the end of life. Journal of Clinical Oncology, 23(24), 5520-5525. https://doi.org/10.1200/JCO.2005.08.391

Emanuel, E. J., Onwuteaka-Philipsen, B. D., Urwin, J. W., & Cohen, J. (2016). Attitudes and practices of euthanasia and physician-assisted suicide in the United States, Canada, and Europe. JAMA, 316(1), 79-90. https://doi.org/10.1001/jama.2016.8499

Ganzini, L., Goy, E. R., & Dobscha, S. K. (2008). Prevalence of depression and anxiety in patients requesting physicians' aid in dying: Cross sectional survey. BMJ, 337, a1682. https://doi.org/10.1136/bmj.a1682

Hendry, M., Pasterfield, D., Lewis, R., Carter, B., Hodgson, D., & Wilkinson, C. (2013). Why do we want the right to die? A systematic review of the international literature on the views of patients, carers and the public on assisted dying. Palliative Medicine, 27(1), 13-26. https://doi.org/10.1177/0269216312463623

Kim, S. Y. H., De Vries, R. G., & Peteet, J. R. (2016). Euthanasia and assisted suicide of patients with psychiatric disorders in the Netherlands 2011 to 2014. JAMA Psychiatry, 73(4), 362-368. https://doi.org/10.1001/jamapsychiatry.2015.2887

Maytal, G., & Stern, T. A. (2006). The desire for death in the setting of terminal illness: A case discussion. Primary Care Companion to the Journal of Clinical Psychiatry, 8(5), 299-305. https://doi.org/10.4088/pcc.v08n0507

Robinson, S., Kissane, D. W., Brooker, J., & Burney, S. (2015). A systematic review of the demoralization syndrome in individuals with progressive disease and cancer: A decade of research. Journal of Pain and Symptom Management, 49(3), 595-610. https://doi.org/10.1016/j.jpainsymman.2014.07.008

Smith, K. A., Goy, E. R., Harvath, T. A., & Ganzini, L. (2011). Quality of death and dying in patients who request physician-assisted death. Journal of Palliative Medicine, 14(4), 445-450. https://doi.org/10.1089/jpm.2010.0425

Sullivan, A. D., Hedberg, K., & Fleming, D. W. (2000). Legalized physician-assisted suicide in Oregon - the second year. New England Journal of Medicine, 342(8), 598-604. https://doi.org/10.1056/NEJM200002243420822

Wilson, K. G., Scott, J. F., Graham, I. D., Kozak, J. F., Chater, S., Viola, R. A., de Faye, B. J., Weaver, L. A., & Curran, D. (2000). Attitudes of terminally ill patients toward euthanasia and physician-assisted suicide. Archives of Internal Medicine, 160(16), 2454-2460. https://doi.org/10.1001/archinte.160.16.2454